582 related articles for article (PubMed ID: 32098276)
1. Treatment of Neonatal Hypoxic-Ischemic Encephalopathy with Erythropoietin Alone, and Erythropoietin Combined with Hypothermia: History, Current Status, and Future Research.
Oorschot DE; Sizemore RJ; Amer AR
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32098276
[TBL] [Abstract][Full Text] [Related]
2. High-Dose Erythropoietin for Asphyxia and Encephalopathy (HEAL): A Randomized Controlled Trial - Background, Aims, and Study Protocol.
Juul SE; Comstock BA; Heagerty PJ; Mayock DE; Goodman AM; Hauge S; Gonzalez F; Wu YW
Neonatology; 2018; 113(4):331-338. PubMed ID: 29514165
[TBL] [Abstract][Full Text] [Related]
3. Effects of EPO combined with mild hypothermia on oxidative stress and neuroprotection in neonates with hypoxic-ischemic encephalopathy.
Xu Y; Huang L; Han J; Zhou Y
Cell Mol Biol (Noisy-le-grand); 2022 Apr; 68(4):36-45. PubMed ID: 35988285
[TBL] [Abstract][Full Text] [Related]
4. Impact of Erythropoietin in the management of Hypoxic Ischaemic Encephalopathy in resource-constrained settings: protocol for a randomized control trial.
Ezenwa B; Ezeaka C; Fajolu I; Ogbenna A; Olowoyeye O; Nwaiwu O; Opoola Z; Olorunfemi G
BMC Neurol; 2020 May; 20(1):171. PubMed ID: 32366288
[TBL] [Abstract][Full Text] [Related]
5. Concurrent erythropoietin and hypothermia treatment improve outcomes in a term nonhuman primate model of perinatal asphyxia.
Traudt CM; McPherson RJ; Bauer LA; Richards TL; Burbacher TM; McAdams RM; Juul SE
Dev Neurosci; 2013; 35(6):491-503. PubMed ID: 24192275
[TBL] [Abstract][Full Text] [Related]
6. Risk of seizures in neonates with hypoxic-ischemic encephalopathy receiving hypothermia plus erythropoietin or placebo.
Glass HC; Wusthoff CJ; Comstock BA; Numis AL; Gonzalez FF; Maitre N; Massey SL; Mayock DE; Mietzsch U; Natarajan N; Sokol GM; Bonifacio SL; Van Meurs KP; Thomas C; Ahmad KA; Heagerty PJ; Juul SE; Wu YW
Pediatr Res; 2023 Jul; 94(1):252-259. PubMed ID: 36470964
[TBL] [Abstract][Full Text] [Related]
7. Erythropoietin in perinatal hypoxic-ischemic encephalopathy: a systematic review and meta-analysis.
Razak A; Hussain A
J Perinat Med; 2019 May; 47(4):478-489. PubMed ID: 30789826
[TBL] [Abstract][Full Text] [Related]
8. Erythropoietin for neonatal brain injury: opportunity and challenge.
Xiong T; Qu Y; Mu D; Ferriero D
Int J Dev Neurosci; 2011 Oct; 29(6):583-91. PubMed ID: 21277366
[TBL] [Abstract][Full Text] [Related]
9. Prolonged astrocyte-derived erythropoietin expression attenuates neuronal damage under hypothermic conditions.
Toriuchi K; Kakita H; Tamura T; Takeshita S; Yamada Y; Aoyama M
J Neuroinflammation; 2020 May; 17(1):141. PubMed ID: 32359362
[TBL] [Abstract][Full Text] [Related]
10. Erythropoietin and hypothermia for hypoxic-ischemic encephalopathy.
Rogers EE; Bonifacio SL; Glass HC; Juul SE; Chang T; Mayock DE; Durand DJ; Song D; Barkovich AJ; Ballard RA; Wu YW
Pediatr Neurol; 2014 Nov; 51(5):657-62. PubMed ID: 25439577
[TBL] [Abstract][Full Text] [Related]
11. Erythropoietin: a novel therapy for hypoxic-ischaemic encephalopathy?
Wu YW; Gonzalez FF
Dev Med Child Neurol; 2015 Apr; 57 Suppl 3():34-9. PubMed ID: 25800490
[TBL] [Abstract][Full Text] [Related]
12. Erythropoietin for infants with hypoxic-ischemic encephalopathy.
McPherson RJ; Juul SE
Curr Opin Pediatr; 2010 Apr; 22(2):139-45. PubMed ID: 20090525
[TBL] [Abstract][Full Text] [Related]
13. High-Dose Erythropoietin and Hypothermia for Hypoxic-Ischemic Encephalopathy: A Phase II Trial.
Wu YW; Mathur AM; Chang T; McKinstry RC; Mulkey SB; Mayock DE; Van Meurs KP; Rogers EE; Gonzalez FF; Comstock BA; Juul SE; Msall ME; Bonifacio SL; Glass HC; Massaro AN; Dong L; Tan KW; Heagerty PJ; Ballard RA
Pediatrics; 2016 Jun; 137(6):. PubMed ID: 27244862
[TBL] [Abstract][Full Text] [Related]
14. Erythropoietin for neuroprotection in neonatal encephalopathy: safety and pharmacokinetics.
Wu YW; Bauer LA; Ballard RA; Ferriero DM; Glidden DV; Mayock DE; Chang T; Durand DJ; Song D; Bonifacio SL; Gonzalez FF; Glass HC; Juul SE
Pediatrics; 2012 Oct; 130(4):683-91. PubMed ID: 23008465
[TBL] [Abstract][Full Text] [Related]
15. Erythropoietin as a Neuroprotective Drug for Newborn Infants: Ten Years after the First Use.
Perrone S; Lembo C; Gironi F; Petrolini C; Catalucci T; Corbo G; Buonocore G; Gitto E; Esposito SMR
Antioxidants (Basel); 2022 Mar; 11(4):. PubMed ID: 35453337
[TBL] [Abstract][Full Text] [Related]
16. Long-Term Neuropathological Changes Associated with Cerebral Palsy in a Nonhuman Primate Model of Hypoxic-Ischemic Encephalopathy.
McAdams RM; Fleiss B; Traudt C; Schwendimann L; Snyder JM; Haynes RL; Natarajan N; Gressens P; Juul SE
Dev Neurosci; 2017; 39(1-4):124-140. PubMed ID: 28486224
[TBL] [Abstract][Full Text] [Related]
17. Cytokine and chemokine responses to injury and treatment in a nonhuman primate model of hypoxic-ischemic encephalopathy treated with hypothermia and erythropoietin.
Wood TR; Vu PT; Comstock BA; Law JB; Mayock DE; Heagerty PJ; Burbacher T; Bammler TK; Juul SE
J Cereb Blood Flow Metab; 2021 Aug; 41(8):2054-2066. PubMed ID: 33554708
[TBL] [Abstract][Full Text] [Related]
18. The effects of monotherapy with erythropoietin in neonatal hypoxic-ischemic encephalopathy on neurobehavioral development: a systematic review and meta-analysis.
Liu TS; Yin ZH; Yang ZH; Wan LN
Eur Rev Med Pharmacol Sci; 2021 Mar; 25(5):2318-2326. PubMed ID: 33755969
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic hypothermia in the prevention of hypoxic-ischaemic encephalopathy: new categories to be enrolled.
Gancia P; Pomero G
J Matern Fetal Neonatal Med; 2012 Oct; 25 Suppl 4():94-6. PubMed ID: 22958032
[TBL] [Abstract][Full Text] [Related]
20. [Therapeutic hypothermia for neonatal hypoxic-ischemic encephalopathy].
Gulczyńska E; Gadzinowski J
Ginekol Pol; 2012 Mar; 83(3):214-8. PubMed ID: 22568198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
